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a r t I C l e S
The function of brain circuitry involves both excitatory and inhibitory signals. Inhibitory signals are mediated primarily by the neuro transmitter GABA, which acts through three classes of transmem brane receptor. The ionotropic GABA A and GABA C receptors are ligandgated ion channels that mediate fast synaptic inhibition 1 . The metabotropic GABA B receptor is a G protein-coupled receptor (GPCR) that produces slow and prolonged inhibitory activity 2, 3 .
GABA B receptor is distributed throughout the mammalian central nervous system. In response to binding of GABA, it regulates the acti vity of Ca 2+ and K + channels, and inhibits the function of adenylyl cyclase through the inhibitory G i /G o protein 2, 3 . Specifically, activa tion of GABA B receptor blocks presynaptic neurotransmitter release through the inhibition of voltagegated Ca 2+ channels; it also stimulates G protein-activated inwardly rectifying K + channels (GIRKs) to gene rate inhibitory postsynaptic potentials 2, 3 . Disruption of GABA B receptor function has been implicated in several neurological diseases, including spasticity, epilepsy, pain and drug abuse 2, 3 . Baclofen, a specific GABA B receptor agonist, is used clinically to treat muscle spasticity in patients with multiple sclerosis, and brain and spinal cord injuries 2, 3 .
The GABA B receptor is a member of the class C GPCR family, which includes metabotropic glutamate receptors (mGluRs), Ca 2+ sensing receptor (CaSR) and some pheromone and taste receptors 4 . Class C receptors possess the characteristic sevenhelix transmembrane domain responsible for receptor activation; however, their ligand binding site is located in a large extracellular Venus flytrap (VFT) module that has sequence homology to bacterial periplasmic amino acid binding proteins 4 .
Most of the available structural information for class C GPCRs is from mGluRs. The crystal structure of the extracellular ligand binding domain of rat mGluR1 has been solved in both the absence and presence of bound glutamate 5 . This domain forms a disulfide linked homodimer 5, 6 . Each protomer exists in a dynamic equilibrium between open and closed conformations, where the closed confor mation is stabilized by binding of glutamate 5 . The homodimeric mGluR1 ectodomain is asymmetric when fully occupied by gluta mate, such that one protomer adopts a closed conformation and the other protomer adopts an open conformation 5 . This results in partial receptor activation; however, full activation requires the closure of both protomers 7 . Glutamate binding also induces a rearrangement of the dimer interface that shortens the distance between the C termini of the two protomers 5 . This rearrange ment may bring the mGluR transmembrane domains together for receptor activation 4, 5, 8, 9 .
Unlike mGluRs and CaSR, which function as disulfidetethered homodimers, the GABA B receptor functions as a heterodimeric assembly of the GABA B R1 (GBR1) and GABA B R2 (GBR2) sub units [10] [11] [12] [13] [14] . The GABA B receptor was the first example of a GPCR that requires heterodimerization for function, and was recently followed by the discovery of obligatory heterodimerization in taste receptors 15 . GABA B heterodimerization masks an endoplasmic reticulum retention signal (ArgSerArgArg) in GBR1, by means of a Cterminal coiled coil interaction, to allow cell surface expression of both subunits 16 . Additionally, heterodimerization is required for ligandinduced G protein signaling 10-14 . a r t I C l e S Previous findings indicate that GABA B receptor subunits work in concert, through a transactivation mechanism, to carry out receptor function 4 . This model stems from asymmetries in both the trans membrane domain and the ectodomain. First, the GBR2 transmem brane domain contains the determinants for G protein signaling, as mutations in either the second or third intracellular loop of GBR2 abolish G protein activation [17] [18] [19] [20] [21] . GBR1 is not required for G protein coupling; nevertheless, its transmembrane domain enhances coupling efficiency 18, 20, 22 . Second, studies using chimeric receptors indicate that both the GBR1 and GBR2 ectodomains are required for full agonistinduced activation of the receptor 18, 22 , even though only the GBR1 ectodomain is involved in ligand recognition 23 . In fact, the GBR2 ectodomain does not bind GABA or any other known ligand 24 . Furthermore, there is evidence of noncovalent contacts between the GBR1 and GBR2 ectodomains 18, 25, 26 . The critical role of the GBR2 ectodomain may partially be attributed to the higher affinity of GBR2bound GBR1 for agonist (refs. 11,14,22,25,26) or to GBR2 ecto domain involvement in signal transduction across the membrane.
It is not known how the GBR2 ectodomain allosterically con trols agonist affinity or why it is critical for efficient transactivation. Furthermore, no structural information is available for GBR2. In an effort to understand the function of the GBR2 ectodomain, we have determined its crystal structure and studied its interaction with the GBR1 ectodomain. These studies allowed us to (i) investigate the mechanism by which the nonligandbinding GBR2 ectodomain increases the affinity of GBR1 for agonist, (ii) propose an open conformation for the GBR2 ectodomain in the activated state and (iii) provide insight into the heterodimeric ectodomain interface and the ligandbinding site.
RESULTS

Interaction of GBR1 and GBR2 ectodomains
We separately expressed and purified the extracellular domains of human GBR1b and GBR2 from baculovirusinfected insect cells. Different Cterminal truncations of GBR1b and GBR2 ectodomains were tested to determine the domain boundary of the VFT module in each subunit (GBR1b VFT and GBR2 VFT ). Free GBR1b VFT formed mostly aggregates, but the properly folded protein could be rescued by the addition of ligand during expression (Supplementary Fig. 1 ). The antagonist CGP54626 (CGP54626 ANT ) was more effective than the agonists GABA or SKF97541 (SKF97541 AGO ) in stabilizing GBR1 VFT , possibly owing to its higher affinity for the receptor. This is consistent with the thermal unfolding profiles obtained by differential scanning calorimetry (DSC), which showed that CGP54626 ANT bound GBR1b VFT (GBR1b VFT CGP54626 ANT ) had a higher melting temperature than SKF97541 AGO bound GBR1b VFT (GBR1b VFT SKF97541 AGO ) (Supplementary Fig. 1 ). In compari son with GBR1b VFT , a larger fraction of secreted GBR2 VFT appeared well folded (Supplementary Fig. 1 ). Both purified GBR1b VFT and GBR2 VFT migrated faster on an SDS gel under nonreducing condi tions than under reducing conditions, indicating the presence of intramolecular disulfide bonds (Supplementary Fig. 1 ). In addition, sizeexclusion chromatography indicated that soluble GBR2 VFT was a monomer, whereas GBR1b VFT appeared to exist in a monomerdimer equilibrium (Supplementary Fig. 1 ).
GBR1b VFT and GBR2 VFT interacted to form a heterodimer. First, size exclusion chromatography experiments demonstrated the for mation of a complex with an estimated molecular mass of 104 kDa (Fig. 1a) . The peak corresponding to this complex contained both GBR1b VFT and GBR2 VFT , as verified by Nterminal sequencing analysis. Individual GBR1b VFT and GBR2 VFT monomers were similar in size, with measured molecular masses of 54.6 kDa and 62.3 kDa, respectively; thus, the mass of the peak containing the complex is consistent with a 1:1 stoichiometry. In addition, excess GBR2 VFT drove complex formation, possibly because free GBR1b VFT was unstable in the absence of its binding partner. Second, direct binding between soluble GBR1b VFT and GBR2 VFT could also be detected using native gel electrophoresis (Fig. 1b) . The observation of a new band in the mixture of GBR1b VFT and GBR2 VFT , along with the dis appearance of the GBR2 VFT band and GBR1b VFT smear, indicated the formation of a complex between the two subunits. This inter action between GBR1b VFT and GBR2 VFT was not ligand dependent (data not shown).
Recombinant GBR1b VFT was capable of recognizing various ligands. We investigated the ligand binding properties of GBR1b VFT by scin tillation proximity assay (SPA) 27 (Fig. 1c-f) . We also studied the effect of GBR2 VFT on ligand binding affinity. In agreement with previous findings 3 , the rank order of inhibition was CGP54626 ANT > SKF97541 AGO > GABA ≈ baclofen AGO . In addi tion, the presence of GBR2 VFT increased the binding affinity of all three agonists to GBR1b VFT , lowering the halfmaximal inhibitory concentration (IC 50 ) of GABA, baclofen AGO and SKF97541 AGO by about 85%. The addition of GBR2 VFT had no effect on the affinity of the antagonist: the IC 50 of CGP54626 ANT remained essentially the same with or without GBR2 VFT . The ability of GBR1b VFT to bind ligands and that of GBR2 VFT to enhance agonist affinity indicate that both recombinant GBR1b VFT and GBR2 VFT were properly folded and functional. Nevertheless, the IC 50 values obtained for all three ligands in the presence of GBR2 VFT were more than five times those of native GABA B receptor 3, 28 (Supplementary Table 1b) , suggesting that the transmembrane domains of GBR1b and GBR2 also regulate ligand affinity.
We measured the direct binding between GBR1b VFT and GBR2 VFT by isothermal titration calorimetry (Fig. 1g,h ). GBR1b VFT protein was produced in the presence of either SKF97541 AGO or CGP54626 ANT . The heterodimeric interaction between GBR2 VFT and GBR1b VFT SKF97541 AGO was the stronger of the two, with a dissociation constant (K d ) of 24.9 nM. The affinity between GBR2 VFT and GBR1b VFT CGP54626 ANT was about fourfold lower (K d = 94.9 nM). The differ ence in binding affinities can be attributed to a much more favorable entropy change (∆S) for the binding of GBR1b VFT SKF97541 AGO to GBR2 VFT , which may be rationalized by greater solvent release on burial of more surface during complex formation. The enthalpy changes (∆H) were comparable for the two exothermic reactions, suggesting that hydrophobic interactions at the heterodimer inter face, which are the determining factors for heat capacity change, are similar in magnitude. The binding stoichiometry between GBR2 VFT and GBR1b VFT was much lower than the 1:1 ratio expected from a heterodimeric complex. One possible explanation is that only a frac tion of GBR1b VFT SKF97541 AGO (42%) and GBR1b VFT CGP54626 ANT (64%) were properly folded. A second possibility is that the binding kinetics involved a fast offrate.
Crystal structure of GBR2 VFT Soluble GBR2 VFT crystallized in two different forms (Supplementary Tables 2 and 3 and Supplementary Fig. 2 ). Form I crystals diffracted to 2.4 Å spacings. The structure was solved using a platinum deriva tive by single isomorphous replacement with anomalous scattering (SIRAS) and refined to an Rvalue of 20.1% (R free = 21.7%). Form II npg a r t I C l e S crystals diffracted to 3.0 Å resolution. The structure was determined by molecular replacement using the form I GBR2 VFT structure as the search model and refined to a final Rfactor of 21.0% (R free = 25.7%).
The GBR2 VFT crystal structure consists of two lobeshaped domains (LB1 and LB2) connected by three short loops (Fig. 2a,b) . Each domain has an αβfold composed of a central βsheet flanked by αhelices. Overall, the molecule has an architecture similar to that found in mGluRs 5, 8, 9 , natriuretic peptide receptors (NPRs) [29] [30] [31] [32] , the Nterminal domain of ionotropic glutamate receptors 33 and bacterial periplasmic binding proteins (for example, leucine/isoleucine/valine binding protein 34 ) .
A protein containing a VFT module can adopt an open or closed conformation, indicated by the hinge angle between its LB1 and LB2 domains. The closed conformation is often associated with agonist binding. Despite different crystal packing environments, the structure of GBR2 VFT is very similar in the two crystal forms, with an identical hinge angle (152°) (Supplementary Table 4) . The LB1 domains can be superimposed with a root mean squared (r.m.s.) deviation of 0.53 Å for 226 C α atoms, and the LB2 domains with an r.m.s. deviation of 0.31 Å for 177 C α atoms. The conformational differences can be primarily attributed to a small change in their interdomain orienta tion, which corresponds to a 7.5° twist around an axis that is roughly perpendicular to that of the domain closure.
Open conformation of the GBR2 VFT structure At approximately 20% sequence identity, the extracellular domain of GBR2 VFT has relatively low sequence homology to that of mGluRs. Nevertheless, GBR2 VFT shares considerable structural homology with the known structures of mGluR1, mGluR3 and mGluR7 (refs. 5,8,9) . The LB1 domains of GBR2 VFT and mGluR1 can be superimposed with an r.m.s. deviation of 1.5 Å for 176 C α atoms, and the LB2 domains with an r.m.s. deviation of 1.6 Å for 138 C α atoms.
In comparison with known mGluR structures, GBR2 VFT has an unusually large hinge angle (forms I and II, 152°), suggesting an open conformation (Fig. 3) . The difference between the interdomain angles of open (~135°) and closed (~110°) conformations of mGluRs is about 20-25° (refs. 5,8,9) . The hinge angle of GBR2 VFT is more than 15° larger than the open conformation observed for free or antagonist bound mGluR1 (Supplementary Table 4) . A structurebased sequence alignment showed that GBR2 VFT has two insertions at the hinge region compared with mGluR structures (Supplementary Fig. 3 ). These include the loop between strand j and helix K in the LB1 domain, and the βhairpin loop between strands o and p in LB2. Residues from these regions form direct hydrogen bonds that bridge the LB1 and LB2 domains (Supplementary Fig. 3 ). These interdomain contacts may serve to stabilize the open conformation of GBR2 VFT . Although the insertions are expected to be present in the structure of GBR1b VFT , residues forming the interdomain contacts in GBR2 VFT are not conserved in GBR1b VFT , thereby allowing GBR1b VFT to close upon agonist binding.
The GBR2 ectodomain differs from known mGluR structures in three other aspects (Fig. 2) . First, the structure of GBR2 VFT features three disulfide bonds, two of which are conserved in the sequence of GBR1b VFT . None of these are conserved in mGluRs. Second, mGluRs have a cysteinerich region between the VFT and transmembrane domains that is replaced by a 15 to 17residue peptide linker in GBR1 npg a r t I C l e S hGBR2  42  hGBR1b  30  rmG1uR1  19  rmG1uR3  23  rmG1uR7  35   hGBR2  124  hGBR1b  119  rmG1uR1  145  rmG1uR3  131  rmG1ur7  140   hGBR2  234  hGBR1b  228  rmG1uR1  267  rmG1uR3  253  rmG1ur7  264   hGBR2  348  hGBR1b  341  rmG1uR1  366  rmG1uR3  349  rmG1uR7  362   hGBR2  424  hGBR1b  418  rmG1uR1  477  rmG1uR3  464  rmG1uR7  475   483  474  592  576 a r t I C l e S and GBR2. Third, the structure of GBR2 VFT has several insertions and deletions when compared with mGluR structures; many of these variations have no known biological implication. The most notable difference is presence of ligand, possibly owing to the location of ligandbinding site at the homodimeric interface instead of at the interdomain cleft. In addition, the presence of Nlinked glycosylation at the cleft [29] [30] [31] [32] may prevent domain closure. The hinge angle of NPRA (141-142°) is closer to that of GBR2 VFT than is that of any known mGluR structure the omission of a loop between helix B and strand c of GBR2 VFT that, in mGluRs, is responsible for the formation of an intermolecular disulfide bond involved in dimerization. Consistent with this observation, GABA B receptor is a noncovalently linked dimer, unlike mGluRs.
A Dali database search identified NPRs, particularly NPRA, as the closest structural homologs to GBR2 VFT . The hinge angles between the LB1 and LB2 domains of NPRs are relatively invariant to the npg a r t I C l e S (Supplementary Table 4) . Given the similarity between GBR2 VFT and NPRs, and the nonligandbinding property of GBR2 VFT , the hinge angle of GBR2 VFT may also remain constant throughout the resting and active states of the GABA B receptor.
GBR2 VFT closure is not required for receptor activation Sequence analysis revealed putative Nlinked glycosylation sites at the interdomain cleft in chicken, honeybee and Caenorhabditis elegans GBR2 VFT ( Supplementary Fig. 4) , which may serve to pre vent domain closure. Furthermore, GBR2 VFT sequence identity across human, chicken, honeybee and C. elegans ranges between 29.4% and 44.9%, suggesting structural conservation across species. Together, these data further suggest that human GBR2 VFT perpetually adopts a rigid open conformation.
To investigate the functional relevance of a constitutively open GBR2 VFT , we introduced an Nlinked glycosylation site at a prime GBR2 VFT location (Asp256) in the interdomain cleft, a position that corresponds to a putative Nlinked glycosylation site in honeybee GBR2 (Supplementary Fig. 4 ) and hence is likely to prevent any poten tial closure in GBR2. To accurately identify molecular weight changes, we used a truncated GBR2 mutant containing only the VFT module and a single transmembrane helix (GBR2 VFT+TM1 ) for gel shift ana lysis (Fig. 4a) . Compared with wildtype GBR2 VFT+TM1 , glycosylation mutant GBR2 VFT+TM1 N256, which contains the mutations D256N and N258S, showed reduced mobility on SDS PAGE, consistent with the presence of additional carbohydrates at Asn256. Furthermore, this reduced mobility corresponds to the molecular weight of the previously characterized glycosylation mutant GBR2 VFT+TM1 N209 (ref. 35 ) with S209N and V211S mutations. In contrast, a glutamine counterpart to the N209 mutant (GBR2 VFT+TM1 Q209) demonstrates a mobility similar to that of wildtype GBR2 VFT+TM1 . Finally, treat ment with the glycosidase PNGase F restored the gel mobility of the GBR2 VFT+TM1 N256 mutant to that of the wildtype GBR2 VFT+TM1 (Fig. 4b) , demonstrating that the extra mass of GBR2 VFT+TM1 N256 was indeed due to glycosylation.
We evaluated the functional consequences of this added glyco sylation at position 256 by means of its effect on ligand binding, G protein coupling efficacy and GIRK channel activation. The ligand binding properties were measured through inhibition by GABA or CGP54626 ANT of the binding of fluorescent CGP54626 ANT red to the receptor. Coexpression of GBR2N256 with wildtype GBR1 resulted in ligand affinities indistinguishable from those of the wildtype heterodimer (Fig. 4c,d and Supplementary Table 5 ). To assay changes in G protein coupling efficacy, we expressed GBR1 and GBR2 with chimeric Gα qi9 protein, which allows coupling to phospholipase C (PLC). GABAinduced inositol phosphate production was statistically the same for wildtype and mutant receptors, indicating that the presence of glycosylation at the cleft does not affect receptor function (Fig. 4e and Supplementary Table 5 ). Finally, in cells transfected to express both GIRK (GIRK1 and GIRK2) and mutant GABA B receptor (GBR1bwt and GBR2N256; Fig. 4f,g ), application of 100 µM GABA activated a large inward current (Fig. 4g) . The magnitude of current potentiation was the same as that observed for wildtype receptor (Fig. 4f) . Together, these results indicate that GBR2 VFT closure is not required for receptor activation.
Mutational analyses of GBR1 VFT -GBR2 VFT interface
On the basis of the structural homology of GBR2 VFT to mGluRs, we constructed models of the heterodimer in the resting state (open open/R) and the putative asymmetric active state (closedopen/A), both featuring GBR2 VFT in the open conformation (Fig. 5a,b) . The dimer interface of the GABA B receptor differs from that of mGluRs in its electrostatic properties. The homodimer interface of mGluRs fea tures a central hydrophobic core in both the active and resting states. In contrast, the GBR2 VFT structure and GBR1b VFT model both exhibit scattered charged and hydrophobic regions, and they appear to electro statically complement one another (Fig. 5c,d) . The potential dimeriza tion surface of GABA B is more polar than that of mGluRs overall.
To identify specific sites that are important for the heterodimeric interaction between GBR1b VFT and GBR2 VFT , we individually mutated several residues in the LB1 domain of each subunit that correspond to those located at the mGluR1 homodimer interface (Fig. 2c) . We then investigated the effect of each mutation on GABA B signaling. We identified three tyrosine residues critical to agonist response.
The GBR2 residue Tyr118 is important for the activation of both GIRK channels and G i protein. First, the single GBR2 mutation Y118A decreased GABAinduced potentiation of GIRK current in HEK293 cells expressing the GIRK channel and GABA B receptor (Fig. 6a,b) . Application of GABA to cells expressing wildtype GABA B receptor at saturating concentrations resulted in the large expected increase in GIRK current density (Figs. 4f and 6b) . In contrast, the GABA induced increase mediated by the GBR2Y118A mutant was only approximately 44% of the wildtype response. Second, the GBR2 Y118A mutation altered G i activity (Fig. 6c) reduced the maximum agonistdependent [ 35 S]GTPγS binding to 23% of that observed in wildtype. These effects of the GBR2Y118A mutation were not due to reduced surface expression, as the level of cell surface expression of GBR2Y118A was similar to that of wild type GBR2, and furthermore, GBR2Y118A facilitated transport to the surface of wildtype GBR1b (data not shown). The residual response of the mutant receptor in both functional assays may be attributed to a direct action of GBR1b VFT on the GBR1 transmembrane domain, which is in turn relayed to the GBR2 transmembrane domain 22 .
Nevertheless, the reduced GIRK channel and G i activities of the GBR2Y118A mutant may well reflect the impaired communication between GBR1 and GBR2 ectodomains. Indeed, the Y118A mutation in GBR2 VFT directly disrupts the interaction between GBR2 VFT and GBR1b VFT . The GBR2 VFT Y118A mutant was expressed in baculovirus infected insect cells and purified as a monomeric protein, indicating that the mutation does not affect the proper folding of GBR2 VFT . Using the SPA technique, we found that the GBR2 VFT Y118A mutant had no effect on the affinity of GBR1b VFT for GABA (Fig. 6d) . In contrast, wildtype GBR2 VFT increased GABA affinity by more than sixfold (Fig. 1c) . This indicates that Tyr118 of GBR2 is crucial for the heterodimeric interaction between GBR1b VFT and GBR2 VFT .
In addition to Tyr118 of GBR2, Tyr113 and Tyr117 of GBR1b also contribute to the heterodimeric interaction. Point mutation of Tyr113 to an alanine decreased agonistinduced [ 35 S]GTPγS binding to 78% of the wildtype value (Fig. 7a) . The effect of the single Y117A muta tion was much more substantial, with a GABAstimulated [ 35 S]GTP γS binding that reached only 33% of the wildtype value (Fig. 7b) . The partially impaired function of each mutant cannot be attributed to reduced surface expression, as both were transported to the cell surface at levels comparable to that of wildtype GBR1b when expressed with wildtype GBR2 (data not shown). As observed with the GBR2Y118A substitution, the GBR1bY113A and GBR1bY117A mutations most likely attenuate agonistinduced receptor function by weakening the heterodimeric interaction between the two subunits. In fact, all three tyrosine residues may participate in heterodimer formation through a combination of hydrophobic contacts and hydrogen bonds.
Mutational analysis of ligand binding site in GBR1b VFT
The residues lining the interdomain cleft of GBR1 and mGluR ecto domains are conserved from C. elegans to human, consistent with their involvement in ligand recognition 24 . In contrast, the corres ponding residues found in GBR2 VFT are not conserved across species and their mutations do not affect receptor activation, con sistent with the fact that GBR2 VFT does not bind any known natural ligand 24 . Furthermore, none of the GBR1 residues critical for ligand binding are conserved in GBR2 (Fig. 2c) .
On the basis of the GBR1b model, we identified residues at the interdomain cleft region that correspond to the ligand binding site of mGluR1 (Fig. 2c) . Some of the residues have been confirmed by previ ous mutagenesis studies to be important for ligand recognition, and these include Ser130, Ser153 and Tyr250 (refs. 36,37) . In this study, we found that Gly151 of GBR1b is also part of this GABA B ligandbinding site (Supplementary Fig. 5 ). First, substitution of Gly151 with a valine essentially abolished binding by the competitive antagonist [ 3 H]CGP54626 ANT (Fig. 8a) . Second, it caused substantial loss of receptor function, as we could see no simulation of [ 35 S]GTPγS binding, even at saturating concentrations of GABA (Fig. 8b) . 
npg a r t I C l e S
The complete loss of function occurred even though the cell surface expression of the GBR1bG151V mutant was comparable to that of wildtype receptor when expressed with wildtype GBR2 (data not shown). These observations indicate that Gly151 of GBR1b is directly involved in the recognition of both antagonist CGP54626 ANT and agonist GABA, possibly through its main chain polar atoms. Mutation of Gly151 to a residue with a branched side chain, such as valine, may prevent the main chain atoms from being accessible to ligand.
DISCUSSION
The GBR2 ectodomain is important in at least two ways to the func tion of the heterodimeric GABA B receptor. First, the GBR2 ecto domain allosterically controls the agonist binding affinity of GBR1 (refs. 11,14,22,25,26) . Second, it is required for efficient agonistinduced receptor activation 18, 22 . Here we demonstrate that, through direct inter action with GBR1b VFT , GBR2 VFT potentiates agonist binding by sta bilizing the agonistbound conformation of GBR1 VFT . We determined the structure of GBR2 VFT , which revealed a polar heterodimer inter face, unlike the hydrophobic homodimer interface of mGluRs. Because of their high sequence homology, GBR2 VFT provided a template for modeling the structure of GBR1b VFT . These structural models have allowed us to identify residues from both subunits that are important for heterodimerization and residues from GBR1b that are involved in ligand recognition. Furthermore, we provide structural and functional evidence of a constitutively open GBR2 VFT , which suggests structural asymmetry in the active state of the GABA B receptor ectodomain.
Previously, timeresolved fluorescence resonance energy transfer (FRET) techniques have demonstrated that GBR1 and GBR2 ecto domains come in close proximity 25 . Additionally, the GBR1 ecto domain is able to immunoprecipitate the GBR2 ectodomain, and their mixture shifts the apparent molecular mass as assessed by sucrose gradient sedimentation 26 . Here we provide evidence of direct binding between GBR1b VFT and GBR2 VFT with a 1:1 stoichiometry. We also confirm previous results indicating that GBR2 increases the affinity of GBR1 for agonist. It has been suggested that this increased affinity occurs by one or both of two mechanisms: either GBR2 directly acts on the ectodomain of GBR1 or it prevents the inhibitory interaction of the GBR1 ectodomain and GBR1 transmembrane domain 25 . Through their measure of the strength of GBR1 VFT GBR2 VFT interaction in the presence of agonist and antagonist, our calorimetry and binding data support the previous hypothesis that the direct contact between GBR1 and GBR2 ectodomains enhances agonist affinity by selectively stabilizing the agonistbound conformation of GBR1 (ref. 25) .
It is not known whether GBR2 VFT can spontaneously open and close. Our structural data suggests that the open conformation of GBR2 VFT is likely to be relatively rigid for four reasons. First, GBR2 VFT has an identical hinge angle in two different crystal packing environments, suggesting that the open conformation may be the thermodynamically favored state of GBR2 VFT . Second, the open conformation of GBR2 VFT is stabilized by interdomain hydrogen bonds in the cleft region. Third, the closed conformation is often associated with ligand binding, and GBR2 VFT is not known to bind any natural ligand 24 . Fourth, the closest structural homolog of GBR2 VFT , NPRA, has a constitutively open conformation in the absence and presence of ligand, possibly owing to the presence of carbohydrates at the cleft 31, 32 .
We have, furthermore, demonstrated that GBR2 VFT closure is not required for receptor activation. Sequence analysis identified three eukaryotic GBR2 subunits notably similar to human GBR2, and these contain native glycosylation sites in the interdomain cleft. Because the structure of GBR2 VFT is likely to be conserved across species, the presence of putative glycosylation sites suggests that the open conformation observed in human GBR2 VFT is rigid. We investigated the functional relevance of a constitutively open GBR2 VFT by block ing any potential closure through insertion of a large glycan at the cleft. This prevention of GBR2 VFT closure had no effect on affinity for ligand or G protein coupling efficacy, further indicating that GBR2 VFT adopts a constitutively open conformation.
The constitutively open conformation of GBR2 VFT suggests that the ectodomain of GABA B receptor functions in an asymmetric way. Specifically, we propose that both GBR1b VFT and GBR2 VFT are in an open conformation in the resting state and that only GBR1b VFT closes upon ligandinduced activation. FRET data suggest that the intracellular loops of the GABA B receptor transmembrane domain also undergo asymmetrical intersubunit rearrangement upon activa tion 38 . Indeed, direct allosteric interactions between the transmem brane domains of the two subunits have been shown to take part in signal transduction 22 . An asymmetric activated dimer has also been observed for several class A and class C GPCRs 39 . For example, the minimal signaling unit of dopamine D2 receptors consists of two receptors and one G protein, with maximal signaling achieved by agonist binding to a single protomer 40 . Class C GPCRs are known to function either as homodimers linked by a disulfide bridge or as obligatory heterodimers. Structural data obtained for the extracel lular ligandbinding domain of mGluR1 indicates that closure of one protomer is sufficient to induce the active conformation of the homodimer, although full activation requires the closure of both ecto domains 5, 7 . Data on positive allosteric modulators of mGluRs further demonstrates that a single transmembrane domain per dimer reaches the active state during receptor activation 41 .
Two models have been proposed for the mechanism of GABA B receptor activation. One model suggests that receptor activation is mediated without higher order rearrangements, by signals relayed within each protomer through direct contacts between the VFT and transmembrane domains. This model is supported by the observation that the peptide linker between the VFT and transmembrane domains can tolerate variations in sequence and length 42 . A second model pro poses that the activation mechanism of GABA B receptor resembles that of mGluRs 4 . Specifically, ligand binding induces a reorientation of the ectodomains of GBR1 and GBR2 relative to each other, thereby bringing the transmembrane domains of the two subunits together to trigger G protein coupling 22 . Both structural and biochemical evidence point to a rigid architecture for the GBR2 ectodomain, which precludes a ligandinduced intramolecular conformational change involving VFT closure. Receptor activation would then depend on higher order rearrangements between GBR1 and GBR2, such as a reorientation of the dimer interface. This supports a signal transduction mechanism npg a r t I C l e S similar to that of mGluRs, indicating that G protein signaling in the major excitatory and inhibitory neurotransmission systems (that is, the glutamatergic and GABAergic systems) involves architectural rear rangements of extracellular domains. It is of note, however, that the constitutively open conformation of the modulatory subunit of GABA B receptor is unique to the inhibitory GABAergic system (Fig. 5a,b) .
METHODS
Methods and any associated references are available in the online version of the paper.
Accession codes. Protein Data Bank: Atomic coordinates and diffraction data have been deposited with accession codes 4F11 (form I GBR2 VFT crystal structure) and 4F12 (form II GBR2 VFT crystal structure).
Note: Supplementary information is available in the online version of the paper.
ONLINE METHODS
Protein expression and purification. The ectodomains of human GBR1 and GBR2 were separately cloned into a pFastBac vector (Invitrogen) for expression. GBR1 has two major isoforms, GBR1a and GBR1b (ref. 28 ). GBR1b VFT contained residues 30-459 with the signal peptide of baculovirus glycoprotein gp67 attached at the N terminus and a Flag tag at the C terminus. GBR1b VFT His included an additional Cterminal His tag. GBR2 VFT contained residues 1-466 and a Cterminal Flag tag. GBR2 VFT Y118A had a single mutation, Y118A. Sf9 insect cells were infected with recombinant baculovirus carrying the GBR1b VFT or GBR2 VFT gene. The target protein was purified from cell super natant using an antiFlag antibody (M2) affinity column followed by gel filtration chromatography. GBR1b VFT was produced in the absence and presence of various ligands (100 µM GABA, 1 µM SKF97541 AGO and 10 µM CGP54626 ANT ); each ligand was present throughout expression. crystallization and data collection. GBR2 VFT was crystallized in two different forms at 20 °C. Form I crystals were grown in 18% polyethylene glycol mono methyl ether 550, 20% glycerol, 2 mM ZnSO 4 and 0.1 M Na cacodylate, pH 6.5, and directly frozen from drops. Diffraction data were measured at the 24IDC beamline of the Advanced Photon Source (APS). A native data set was collected to 2.4 Å. A platinum derivative was obtained by soaking crystals with 5 mM K 2 PtCl 4 ; its diffraction extended to 3.8 Å.
Form II crystals were obtained from 30% Jeffamine ED2001, and 0.1 M HEPES, pH 7.0. The crystals were soaked in a cryoprotectant containing 20% PEG400 and reservoir solution, then flashcooled with liquid nitrogen. A native data set was collected to 3.0 Å at X4C beamline of the National Synchrotron Light Source (NSLS).
Structure determination. The structure of GBR2 VFT in crystal form I was solved by single isomorphous replacement with anomalous scattering (SIRAS). The positions of Pt atoms in the derivative crystal were located with HKL2MAP 43 using anomalous differences of Pt atoms at the LIII edge (1.072 Å). Refinement of heavy atom parameters, phase calculation and density modification were per formed with SHARP 44 at 50-3.8 Å, using both anomalous and isomorphous dif ferences from the native and derivative data sets. Based on the 3.8 Å SIRAS maps, we traced the backbone of GBR2 VFT with COOT. This initial model was refined against the native data to 2.4 Å using BUSTER 45 . A complete atomic model of GBR2 VFT was developed through iterative model building and refinement. The last stages of refinement were carried out in REFMAC 46 .
The final model of GBR2 VFT contains protein residues 52-293 and 300-466, the entire Cterminal Flag tag, 1 Nacetylglucosamine, 1 fucose, 2 Zn 2+ ions and 142 water molecules. Ramachandran analysis performed with MolProbity 47 places 97.3% of all residues in favored regions and 0.24% in outlier regions.
The form II structure was solved by molecular replacement using the form I structure as the search model. Refinement was carried out in BUSTER 45 and at the last stages in REFMAC 46 . The final structure contains GBR2 VFT residues 49-293 and 302-466, 5 Nacetylglucosamines, 1 fucose and 96 water molecules. Geometric analysis using MolProbity 47 places 95.1% of all residues in favored regions and 1.2% as outliers.
Structural analysis and homology modeling. The interdomain hinge angle is defined as the angle formed by the centers of mass of LB1 and LB2 domains about a central pivot point in the interdomain linker region. The center of mass for each domain was calculated using the TABFUN function of AMoRE 48 .
A homology model was created for GBR1b VFT based on the GBR2 VFT struc ture using Modeller 49 . The open conformation of GBR1b VFT was generated by superimposing its LB1 and LB2 domains separately onto the structure of an open conformer of mGluR1 (1EWT, B chain) 5 . The closed conformation of GBR1b VFT was generated similarly using a closed conformer of mGluR1 (1EWK, A chain) 5 . The structure of free mGluR1 (1EWT) 5 served as a template to model the resting state of a GBR1b VFT GBR2 VFT heterodimer, with both GBR1b VFT and GBR2 VFT in the open conformation (OpenOpen/R). The structure of glutamatebound mGluR1 (1EWK) 5 was used to model the active state, with GBR1b in the closed conformation and GBR2 in the open conformation (ClosedOpen/A).
Scintillation proximity assay. Yttrium silicate (YSI) Cu 2+ Histag SPA beads (PerkinElmer) (250 µg) were added to GBR1b VFT His (0.5 µg), a mixture of GBR1b VFT His (0.5 µg) and GBR2 VFT (1.0 µg) , or a mixture of GBR1b VFT His (0.5 µg) and GBR2 VFT Y118A (1.0 µg) preincubated with 100 nM [ 3 H]GABA (35 Ci/mmol) at 4 °C. Increasing concentrations of nonradioactive GABA, baclofen AGO , SKF97541 AGO or CGP54626 ANT were added to compete for receptor binding. Each reaction was also performed in the presence of 800 mM imida zole for background correction. The plates were counted in a Microbeta counter (PerkinElmer). Data were analyzed using the nonlinear regression algorithms in Prism (GraphPad).
Isothermal titration calorimetry. The titration calorimetry experiments were carried out in an ITC200 calorimeter (MicroCal) at 15 °C. GBR1b VFT SKF97541 AGO protein was placed in the sample cell at 19.35 µM, and GBR2 VFT was added from a 81.65 µM stock in 1.5µl injections. The titration was carried out until GBR1b VFT SKF97541 AGO was saturated with GBR2 VFT . Similarly, GBR1b VFT CGP54626 ANT was placed in the sample cell at 13.91 µM and titrated with 1.5µl injections of 52.24 µM GBR2 VFT . For each titration, the heat effects of buffer dilution were measured in a control experiment in which the GBR2 VFT protein was titrated into the buffer following the same injection schedule as the sample titration. Data were analyzed using MicroCal Origin. After subtracting the control data, the sample titration was fit to a singlebinding site model. differential scanning calorimetry. Temperatureinduced protein unfolding of GBR1b VFT SKF97541 AGO and GBR1b VFT CGP54626 ANT was measured using a VPCapillary differential scanning calorimeter (MicroCal) at a heat ing rate of 2 K/min. The thermal transition midpoint (T m ) of GBR1b VFT SKF97541 AGO and GBR1b VFT CGP54626 ANT were measured at protein concentrations of 11.58 µM and 25.65 µM, respectively. Data were analyzed with MicroCal Origin. western blot. A truncated GBR2 subunit containing only the VFT module and first transmembrane helix (GBR2 VFT+TM1 ) was subcloned into a pRK5 vector with an Nterminal hemagglutinin (HA) tag. The GBR2 VFT+TM1 N256 mutant contained mutations D256N and N258S. The mutant GBR2 VFT+TM1 N209 carries mutations S209N and V211S, and GBR2 VFT+TM1 Q209 carries mutations S209Q and V211S (ref. 35) .
Human embryonic kidney (HEK293) cells transfected with each plasmid were harvested to obtain the membrane fraction. Deglycosylation of GBR2 VFT+TM1 and GBR2 VFT+TM1 N256 was carried out using PNGase F (Roche) under denaturing conditions. Western blot analysis was performed using a rabbit polyclonal antiHA antibody (Life Technologies) 24 . Proteins were visualized by electro chemiluminescence.
Inositol phosphate measurement. Wildtype fulllength GBR1a (GBR1awt) tagged at its Nterminal end with a Flag epitope followed by a snaptag was inserted into a pRK5 plasmid 50 . Similarly, pRK5 plasmids containing wildtype fulllength GBR2 (GBR2wt) 18, 35 and a glycosylation mutant (GBR2N256, with mutations D256N and N258S) tagged at their Nterminal ends with an HA epitope were generated.
Measurement of inositol phosphate accumulation was carried out as described 51 using HEK293 cells cotransfected with GBR1awt, GBR2wt or GBR2N256, and Gα qi9 . Briefly, after labeling with [ 3 H]myoinositol, cells were stimulated with or without ligand. The inositol phosphates produced were purified by ionexchange chromatography. Radioactivity was measured using a MicroBeta counter. Results are expressed as the ratio between inositol phosphate and the total radioactivity present in the membranes and normalized to the maximal stimulation. Data were analyzed using the nonlinear regression algorithms in Prism. 
